1. Klemm, F., and J. A. Joyce. 2015. Microenvironmental
regulation of therapeutic response in cancer. Trends Cell
Biol. 25: 198– 213.
2. Muller, M., S. Carter, M. J. Hofer, and I. L.Campbell. 2010. Review: the chemokine receptor CXCR3 and
its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity–a
tale of conflict and conundrum. Neuropathol. Appl.
Neurobiol. 36: 368– 387.
3. Smit, M. J., P. Verdijk, E. M. van der Raaij‐Helmer, M. Navis, P.
J. Hensbergen, R. Leurs, et al. 2003. CXCR3‐mediated chemotaxis
of human T cells is regulated by a Gi‐ and phospholipase C‐
dependent pathway and not via activation of MEK/p44/p42
MAPK nor Akt/PI‐3 kinase. Blood 102: 1959– 1965.
4. Muthuswamy, R., J. Urban, J. J. Lee, T. A. Reinhart, D. Bartlett,
and P. Kalinski. 2008. Ability of mature dendritic cells to interact
with regulatory T cells is imprinted during maturation. Cancer
Res. 68: 5972– 5978.
5. Ikeda, A., N. Aoki, M. Kido, S. Iwamoto, H. Nishiura, R.
Maruoka, et al. 2014. Progression of autoimmune hepatitis is
mediated by IL‐18‐producing dendritic cells and hepatic CXCL9
expression in mice. Hepatology 60: 224– 236.
6. Tworek, D., P. Kuna, W. Mlynarski, P. Gorski, T. Pietras,
and A. Antczak. 2013. MIG (CXCL9), IP‐10 (CXCL10) and I‐
TAC (CXCL11) concentrations after nasal allergen challenge in
patients with allergic rhinitis. Arc. Med. Sci. 9: 849– 853.
7. Holt, A. P., E. L. Haughton, P. F. Lalor, A. Filer, C. D.
Buckley, and D. H. Adams. 2009. Liver myofibroblasts
regulate infiltration and positioning of lymphocytes in human
liver. Gastroenterology 136: 705– 714.
8. Antonelli, A., S. M. Ferrari, P. Fallahi, S. Frascerra, E. Santini, S.
S. Franceschini, et al. 2009. Monokine induced by interferon
gamma (IFNgamma) (CXCL9) and IFNgamma inducible T‐cell
alpha‐chemoattractant (CXCL11) involvement in Graves’ disease
and ophthalmopathy: modulation by peroxisome proliferator‐
activated receptor‐gamma agonists. J. Clin. Endocrinol.
Metabol. 94: 1803– 1809.
9. Vandercappellen, J., J. Van Damme, and S. Struyf. 2008. The
role of CXC chemokines and their receptors in cancer. Cancer
Lett. 267: 226– 244.
10. Hiroi, M., and Y. Ohmori. 2003. The transcriptional
coactivator CREB‐binding protein cooperates with STAT1 and
NF‐kappa B for synergistic transcriptional activation of the CXC
ligand 9/monokine induced by interferon‐gamma gene. J. Biol.
Chem. 278: 651– 660.
11. Staab, J., C. Herrmann‐Lingen, and T. Meyer. 2013. Clinically
relevant dimer interface mutants of STAT1 transcription factor
exhibit differential gene expression. PLoS ONE 8: e69903.
12. Chung, E. Y., B. H. Kim, J. T. Hong, C. K. Lee, B. Ahn, S.
Y. Nam, et al. 2011. Resveratrol down‐regulates interferon‐
gamma‐inducible inflammatory genes in macrophages:
molecular mechanism via decreased STAT‐1 activation. J. Nutr.
Biochem. 22: 902– 909.
13. Chung, E. Y., E. Roh, J. A. Kwak, H. S. Lee, S. H. Lee, C. K.
Lee, et al. 2010. alpha‐Viniferin suppresses the signal transducer
and activation of transcription‐1 (STAT‐1)‐inducible inflammatory
genes in interferon‐gamma‐stimulated macrophages.J. Pharmacol.
Sci. 112: 405– 414.
14. Jauregui, C. E., Q. Wang, C. J. Wright, H. Takeuchi, S. M.
Uriarte, and R. J. Lamont. 2013. Suppression of T‐cell chemokines
by Porphyromonas gingivalis. Infect. Immun. 81: 2288– 2295.
15. Kim, W. H., F. Hong, S. Radaeva, B. Jaruga, S. Fan, and B.
Gao. 2003. STAT1 plays an essential role in LPS/D‐galactosamine‐
induced liver apoptosis and injury. Am. J. Physiol. Gastrointest.
Liver Physiol. 285: G761– G768.
16. Mariman, R., F. Tielen, F. Koning, and L.
Nagelkerken. 2014. The probiotic mixture VSL#3 dampens
LPS‐induced chemokine expression in human dendritic cells by
inhibition of STAT‐1 phosphorylation. PLoS ONE 9: e115676.
17. Basset, L., S. Chevalier, Y. Danger, M. I. Arshad, C. Piquet‐
Pellorce, H. Gascan, et al. 2015. Interleukin‐27 and IFNgamma
regulate the expression of CXCL9, CXCL10, and CXCL11 in
hepatitis. J. Mol. Med. 93: 1355– 1367.
18. Xia, L. M., W. J. Huang, J. G. Wu, Y. B. Yang, Q. Zhang, Z.
Z. Zhou, et al. 2009. HBx protein induces expression of MIG
and increases migration of leukocytes through activation of NF‐
kappaB. Virology 385: 335– 342.
19. Ellis, S. L., V. Gysbers, P. M. Manders, W. Li, M. J. Hofer, M.
Muller, et al. 2010. The cell‐specific induction of CXC chemokine
ligand 9 mediated by IFN‐gamma in microglia of the central
nervous system is determined by the myeloid transcription factor
PU.1. J. Immunol. 185: 1864– 1877.
20. Kanno, Y., B. Z. Levi, T. Tamura, and K. Ozato. 2005. Immune
cell‐specific amplification of interferon signaling by the IRF‐4/8‐
PU.1 complex. J. Interferon Cytokine Res. 25: 770– 779.